Meet new Team Leader, Dr Charles de Bock

28/02/2019


Last year we recruited our first two Team Leaders in a newly created role. One of them was Dr Charles de Bock. He was working in Belgium at the time but has since returned to Australia, and he took up the Team Leader position last month. Let’s find out something about him.

'

Our researchers combine an old drug with a new one to starve neuroblastoma

18/02/2019


Our researchers have found a way to dramatically slow neuroblastoma growth, using a combination of drugs that starves cells of essential nutrients called polyamines.

'

Researcher travels 14,500 km to find better treatments for neuroblastoma

31/01/2019


Research Assistant Olivia Ciampa recently spent six months working in a collaborator’s lab at the Mayo Clinic, Minnesota, USA. I asked her why she went there, what it was like, and what she achieved.

'

Fundamental mechanism behind chemotherapy resistance revealed

17/12/2018


Groundbreaking research from our Leukaemia Biology Program has revealed how acute lymphoblastic leukaemia can become resistant to a class of anti-cancer drugs called glucocorticoids.

'

New imaging method could help treat and monitor neuroblastoma

19/11/2018


Our researchers have developed a method to measure the amount of copper inside neuroblastoma tumours. Published in the journal Theranostics, it offers a potential tool for treating and monitoring neuroblastoma.

'

Great Cop Drop is windfall for childhood cancer research

02/11/2018


Twenty-six police officers and one cancer researcher took to the skies last Sunday to raise funds for childhood cancer research. The inaugural Great Cop Drop was inspired by Isla, a little girl diagnosed with leukaemia four years ago.

'

New drug OBI-3424 designated an ‘Orphan Drug’ to treat acute lymphoblastic leukaemia

19/10/2018


A drug called OBI-3424 has been designated an Orphan Drug by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukaemia, based predominantly on research carried out by our Leukaemia Biology Program.

'

A little girl’s legacy: Olivia Lambert Team Leader appointed

28/09/2018


Olivia Lambert was a bright and happy little girl with an infectious smile and a fun-loving spirit. Diagnosed with stage 4 neuroblastoma at age two and a half, she fought the disease bravely for six years. Her legacy and spirit continue with the appointment of Dr Joshua McCarroll as the Olivia Lambert Team Leader.

'

Awareness Wednesday: Drug Discovery

19/09/2018


This week we’re looking at Drug Discovery – the development of new cancer treatments. Because it’s only with more effective, less toxic cancer drugs that we’ll be able to save the life of every child with cancer and improve their long-term health.

'

Let’s talk about nanomedicine

05/07/2018


The 9th International Nanomedicine Conference was held last week in Coogee, Sydney. Some of our researchers were there, showcasing their research and networking with colleagues from near and far.

'cells containing green fluorescently-labelled nanoparticles